MAO inhibitors like Parnate
block the enzyme monoarnine oxidase, which breaks down serotonin and norepinephrine.
, prescribed for mental depression, was eventually proven to cause brain damage.
Studies show that tryptophan enhances the effect of some of these drugs, including Parnate
has received final approval to market tranylcypromine sulfate tablets, the generic version of GlaxoSmithKline PLC's Parnate